Global Down Syndrome

Issue 1 of 4 - 2018

Issue link: https://viewer.e-digitaledition.com/i/960711

Contents of this Issue

Navigation

Page 7 of 31

A STANDING OVATION, A TESTIMONY THAT WENT VIRAL, AND BIPARTISAN SUPPORT DEFINE A FIRST-EVER CONGRESSIONAL HEARING FOCUSED ON DOWN SYNDROME RESEARCH. Republicans and Democrats Agree: Increase NIH Funding for Down Syndrome Research THE GLOBAL DOWN SYNDROME FOUNDATION has been working with the National Institutes of Health (NIH) and members of the U.S. House of Representatives and Senate for nearly a decade advocating for increased federal funding for research benefiting people with Down syndrome. That work culminated in a first-ever hearing on Down syndrome research before the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies held in October 2017. The subcommittee's leadership, Chair Rep. Tom Cole (R-OK) and ranking member Rep. Rosa DeLauro (D-CT), organized the momentous hearing, "Down Syndrome: Update on the State of the Science & Potential for Discoveries Across Other Major Diseases," to explore how Down syndrome research can improve the lives of people with the condition and lead to new treatments for life-altering medical conditions, including Alzheimer's disease, autoimmune disorders, and cancer. This hearing could spur the kinds of change the Down syndrome community has been waiting for. FUNDING LEVELS HAVE YET TO RECOVER FROM UNPRECEDENTED 2001 CUTS Despite being the leading cause of developmental delay in the U.S. and the world, Down syndrome is one of the least-funded genetic conditions by the NIH and has been for the last 19 years. The hearing allowed Global to highlight the precipitous decline in Down syndrome research funding at the NIH: from $29 million in 2001 to $14 million in 2006. Unfortunately, despite double-digit growth of the overall NIH budget in the following years, the funding for Down syndrome research never recovered. In 2017, the funding was $27 million, still well below 2001 levels and dramatically smaller compared with the overall NIH budget. Many committee members were surprised by this funding disparity, and several voiced their support for funding increases. Rep. Cathy McMorris Rodgers (R-WA) was a key spokesperson at the hearing and has a 10-year-old son, Cole, who happens to have Down syndrome. She underscored groundbreaking research related to Down syndrome, the immune system, and Alzheimer's disease. "Even though Congress has substantially and consistently increased the NIH budget in recent years — in large part thanks to the work of this subcommittee — funding for Down syndrome research makes up less than 100th of a percent of the total budget," she said. "The year Cole was born the NIH provided $16 million for Down syndrome research," she continued. "Today, it's approximately $27 million. With more than 400,000 Americans living with Down syndrome that's less than $100 of research per individual [per year]." Rep. Andy Harris (R-MD), who is also a physician, noted, "We've spent 25 times more per person with HIV/AIDS than we do with Down [syndrome]. And remember in 1980, when I graduated from medical school, both had similar reputations. Now why is it [that Down syndrome funding has not increased]? I'll suggest because we don't Rep. Tom Cole (R-OK) (center) with (from lef t) Doris and Aaron Er har t and Heather and Lisa Hancock of Oklahoma City 2018 ISSUE 1 OF 4 • DOWN SYNDROME WORLD ™ 8

Articles in this issue

Archives of this issue

view archives of Global Down Syndrome - Issue 1 of 4 - 2018